|
1
|
Meier FM, Frerix M, Hermann W and
Muller-Ladner U: Current immunotherapy in rheumatoid arthritis.
Immunotherapy. 5:955–974. 2013.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Boissier MC, Semerano L, Challal S,
Saidenberg-Kermanac'h N and Falgarone G: Rheumatoid arthritis: From
autoimmunity to synovitis and joint destruction. J Autoimmun.
39:222–228. 2012.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Tobon GJ, Youinou P and Saraux A: The
environment, geo-epidemiology, and autoimmune disease: Rheumatoid
arthritis. J Autoimmun. 35:10–14. 2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Rockel JS and Kapoor M: Autophagy:
Controlling cell fate in rheumatic diseases. Nat Rev Rheumatol.
13(193)2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Bartok B, Hammaker D and Firestein GS:
Phosphoinositide 3-kinase delta regulates migration and invasion of
synoviocytes in rheumatoid arthritis. J Immunol. 192:2063–2070.
2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Qin B, Yang M, Fu H, Ma N, Wei T, Tang Q,
Hu Z, Liang Y, Yang Z and Zhong R: Body mass index and the risk of
rheumatoid arthritis: A systematic review and dose-response
meta-analysis. Arthritis Res Ther. 17(86)2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Qin B, Liang Y, Yang Z and Zhong R:
Response to: ‘Body mass index and the risk of rheumatoid arthritis:
A systematic review and dose-response meta-analysis’-authors'
reply. Arthritis Res Ther. 17(217)2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lee RC, Feinbaum RL and Ambros V: The C.
Elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kozomara A and Griffiths-Jones S: miRBase:
Integrating microRNA annotation and deep-sequencing data. Nucleic
Acids Res. 39:D152–D157. 2011.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Filkova M, Jungel A, Gay RE and Gay S:
MicroRNAs in rheumatoid arthritis: Potential role in diagnosis and
therapy. BioDrugs. 26:131–141. 2012.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Li S, Jin Z and Lu X: MicroRNA-192
suppresses cell proliferation and induces apoptosis in human
rheumatoid arthritis fibroblast-like synoviocytes by downregulating
caveolin 1. Mol Cell Biochem. 432:123–130. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kurowska-Stolarska M, Alivernini S,
Melchor EG, Elmesmari A, Tolusso B, Tange C, Petricca L, Gilchrist
DS, Di Sante G, Keijzer C, et al: MicroRNA-34a dependent regulation
of AXL controls the activation of dendritic cells in inflammatory
arthritis. Nat Commun. 8(15877)2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Gao W, McCormick J, Connolly M, Balogh E,
Veale D and Fearon U: Hypoxia and STAT3 signalling interactions
regulate pro-inflammatory pathways in rheumatoid arthritis. Ann
Rheum Dis. 74:1275–1283. 2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Isomaki P, Junttila I, Vidqvist KL,
Korpela M and Silvennoinen O: The activity of JAK-STAT pathways in
rheumatoid arthritis: constitutive activation of STAT3 correlates
with interleukin 6 levels. Rheumatology (Oxford). 54:1103–1113.
2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Nowell MA, Richards PJ, Fielding CA,
Ognjanovic S, Topley N, Williams AS, Bryant-Greenwood G and Jones
SA: Regulation of pre-B cell colony-enhancing factor by
STAT-3-dependent interleukin-6 tranes-signaling: Implications in
the pathogenesis of rheumatoid arthritis. Arthritis Rheum.
54:2084–2095. 2006.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Turkson J and Jove R: STAT proteins: Novel
molecular targets for cancer drug discovery. Oncogene.
19:6613–6626. 2000.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Turkson J, Bowman T, Garcia R, Caldenhoven
E, De Groot RP and Jove R: Stat3 activation by src induces specific
gene regulation and is required for cell transformation. Mol Cell
Biol. 18:2545–2552. 1998.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chen Z and Han ZC: STAT3: A critical
transcription activator in angiogenesis. Med Res Rev. 28:185–200.
2008.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Devarajan E and Huang S: STAT3 as a
central regulator of tumor metastases. Curr Mol Med. 9:626–633.
2009.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Starr R, Willson TA, Viney EM, Murray LJ,
Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA
and Hilton DJ: A family of cytokine-inducible inhibitors of
signalling. Nature. 387:917–921. 1997.PubMed/NCBI View
Article : Google Scholar
|
|
21
|
Endo TA, Masuhara M, Yokouchi M, Suzuki R,
Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H,
et al: A new protein containing an SH2 domain that inhibits JAK
kinases. Nature. 387:921–924. 1997.PubMed/NCBI View
Article : Google Scholar
|
|
22
|
Coombs JH, Bloom BJ, Breedveld FC,
Fletcher MP, Gruben D, Kremer JM, Burgos-Vargas R, Wilkinson B,
Zerbini CA and Zwillich SH: Improved pain, physical functioning and
health status in patients with rheumatoid arthritis treated with
CP-690,550, an orally active Janus kinase (JAK) inhibitor: Results
from a randomised, double-blind, placebo-controlled trial. Ann
Rheum Dis. 69:413–416. 2010.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Tanaka Y, Suzuki M, Nakamura H, Toyoizumi
S and Zwillich SH: Tofacitinib Study Investigators. Phase II study
of tofacitinib (CP-690,550) combined with methotrexate in patients
with rheumatoid arthritis and an inadequate response to
methotrexate. Arthritis Care Res (Hoboken). 63:1150–1158.
2011.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Dong W, Yao C, Teng X, Chai J, Yang X and
Li B: miR-140-3p suppressed cell growth and invasion by
downregulating the expression of ATP8A1 in non-small cell lung
cancer. Tumour Biol. 37:2973–2985. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Wang Z, Hu J, Pan Y, Shan Y, Jiang L, Qi X
and Jia L: miR-140-5p/miR-149 affects chondrocyte proliferation,
apoptosis, and autophagy by targeting FUT1 in osteoarthritis.
Inflammation. 41:959–971. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Flamini V, Jiang WG and Cui Y: Therapeutic
role of miR-140-5p for the treatment of non-small cell lung cancer.
Anticancer Res. 37:4319–4327. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Li W and He F: Monocyte to macrophage
differentiation-associated (MMD) targeted by miR-140-5p regulates
tumor growth in non-small cell lung cancer. Biochem Biophys Res
Commun. 450:844–850. 2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Xie WB, Liang LH, Wu KG, Wang LX, He X,
Song C, Wang YQ and Li YH: miR-140 expression regulates cell
proliferation and targets PD-L1 in NSCLC. Cell Physiol Biochem.
46:654–663. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Yuan Y, Shen Y, Xue L and Fan H: miR-140
suppresses tumor growth and metastasis of non-small cell lung
cancer by targeting insulin-like growth factor 1 receptor. PLoS
One. 8(e73604)2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Song B, Wang Y, Xi Y, Kudo K, Bruheim S,
Botchkina GI, Gavin E, Wan Y, Formentini A, Kornmann M, et al:
Mechanism of chemoresistance mediated by miR-140 in human
osteosarcoma and colon cancer cells. Oncogene. 28:4065–4074.
2009.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Wei R, Cao G, Deng Z, Su J and Cai L:
miR-140-5p attenuates chemotherapeutic drug-induced cell death by
regulating autophagy through inositol 1,4,5-trisphosphate kinase 2
(IP3k2) in human osteosarcoma cells. Biosci Rep.
36(e00392)2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Xiao Q, Huang L, Zhang Z, Chen X, Luo J,
Zhang Z, Chen S, Shu Y, Han Z and Cao K: Overexpression of miR-140
inhibits proliferation of osteosarcoma cells via suppression of
histone deacetylase 4. Oncol Res. 25:267–275. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Li H, Guan SB, Lu Y and Wang F: miR-140-5p
inhibits synovial fibroblasts proliferation and inflammatory
cytokines secretion through targeting TLR4. Biomed Pharmacother.
96:208–214. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Liu X, Wang S, Yuan A, Yuan X and Liu B:
MicroRNA-140 represses glioma growth and metastasis by directly
targeting ADAM9. Oncol Rep. 36:2329–2338. 2016.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Rothman AM, Arnold ND, Pickworth JA,
Iremonger J, Ciuclan L, Allen RM, Guth-Gundel S, Southwood M,
Morrell NW, Thomas M, et al: MicroRNA-140-5p and SMURF1 regulate
pulmonary arterial hypertension. J Clin Invest. 126:2495–2508.
2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhang R, Ma J and Yao J: Molecular
mechanisms of the cartilage-specific microRNA-140 in
osteoarthritis. Inflamm Res. 62:871–877. 2013.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Aggarwal R, Rider LG, Ruperto N, Bayat N,
Erman B, Feldman BM, Oddis CV, Amato AA, Chinoy H, Cooper RG, et
al: 2016 American college of rheumatology/european league against
rheumatism criteria for minimal, moderate, and major clinical
response in adult dermatomyositis and polymyositis: An
international myositis assessment and clinical studies
group/paediatric rheumatology international trials organisation
collaborative initiative. Ann Rheum Dis. 76:792–801.
2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 12(4)2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Lan H, Chen W, He G and Yang S: miR-140-5p
inhibits ovarian cancer growth partially by repression of PDGFRA.
Biomed Pharmacother. 75:117–122. 2015.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Alsaleh G, Francois A, Philippe L, Gong
YZ, Bahram S, Cetin S, Pfeffer S, Gottenberg JE, Wachsmann D,
Georgel P and Sibilia J: miR-30a-3p negatively regulates BAFF
synthesis in systemic sclerosis and rheumatoid arthritis
fibroblasts. PLoS One. 9(e111266)2014.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Alivernini S, Kurowska-Stolarska M,
Tolusso B, Benvenuto R, Elmesmari A, Canestri S, Petricca L,
Mangoni A, Fedele AL, Di Mario C, et al: MicroRNA-155 influences
B-cell function through PU.1 in rheumatoid arthritis. Nat Commun.
7(12970)2016.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Chen SY: MicroRNA-223: A double-edged
sword in rheumatoid arthritis. Rheumatol Int. 34:285–286.
2014.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Shi DL, Shi GR, Xie J, Du XZ and Yang H:
MicroRNA-27a inhibits cell migration and invasion of
fibroblast-like synoviocytes by targeting follistatin-like protein
1 in rheumatoid arthritis. Mol Cells. 39:611–618. 2016.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Chen Y, Xian PF, Yang L and Wang SX:
MicroRNA-21 promotes proliferation of fibroblast-like synoviocytes
through mediation of NF-κB nuclear translocation in a rat model of
collagen-induced rheumatoid arthritis. Biomed Res Int.
2016(9279078)2016.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Zhang F and Wu Z: Significantly altered
expression of miR-511-3p and its target AKT3 has negative
prognostic value in human prostate cancer. Biochimie. 140:66–72.
2017.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Pais H, Nicolas FE, Soond SM, Swingler TE,
Clark IM, Chantry A, Moulton V and Dalmay T: Analyzing mRNA
expression identifies Smad3 as a microRNA-140 target regulated only
at protein level. RNA. 16:489–494. 2010.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Sun J, Shi R, Zhao S, Li X, Lu S, Bu H, Ma
X and Su C: E2F8, a direct target of miR-144, promotes papillary
thyroid cancer progression via regulating cell cycle. J Exp Clin
Cancer Res. 36(40)2017.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Masuda M, Suzui M, Yasumatu R, Nakashima
T, Kuratomi Y, Azuma K, Tomita K, Komiyama S and Weinstein IB:
Constitutive activation of signal transducers and activators of
transcription 3 correlates with cyclin D1 overexpression and may
provide a novel prognostic marker in head and neck squamous cell
carcinoma. Cancer Res. 62:3351–3355. 2002.PubMed/NCBI
|
|
51
|
Kim BH, Yi EH and Ye SK: Signal transducer
and activator of transcription 3 as a therapeutic target for cancer
and the tumor microenvironment. Arch Pharm Res. 39:1085–1099.
2016.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Cafferkey C and Chau I: Novel STAT 3
inhibitors for treating gastric cancer. Expert Opin Investig Drugs.
25:1023–1031. 2016.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Bosch-Barrera J, Queralt B and Menendez
JA: Targeting STAT3 with silibinin to improve cancer therapeutics.
Cancer Treat Rev. 58:61–69. 2017.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Xiong H, Zhang ZG, Tian XQ, Sun DF, Liang
QC, Zhang YJ, Lu R, Chen YX and Fang JY: Inhibition of JAK1,
2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces
tumor cell invasion in colorectal cancer cells. Neoplasia.
10:287–297. 2008.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Liu Y, Li PK, Li C and Lin J: Inhibition
of STAT3 signaling blocks the anti-apoptotic activity of IL-6 in
human liver cancer cells. J Biol Chem. 285:27429–27439.
2010.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Aoki Y, Feldman GM and Tosato G:
Inhibition of STAT3 signaling induces apoptosis and decreases
survivin expression in primary effusion lymphoma. Blood.
101:1535–1542. 2003.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Meng Q, Du X, Wang H, Gu H, Zhan J and
Zhou Z: Astragalus polysaccharides inhibits cell growth and
pro-inflammatory response in IL-1β-stimulated fibroblast-like
synoviocytes by enhancement of autophagy via PI3K/AKT/mTOR
inhibition. Apoptosis. 22:1138–1146. 2017.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Li J, Li Y, Jiao J, Wang J, Li Y, Qin D
and Li P: Mitofusin 1 is negatively regulated by microRNA 140 in
cardiomyocyte apoptosis. Mol Cell Biol. 34:1788–1799.
2014.PubMed/NCBI View Article : Google Scholar
|
